Trial Profile
A retrospective study to evaluate the feasibility and safety of S-1 (Gimeracil/oteracil/tegafur) adjuvant chemotherapy in elderly pancreatic cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 05 Nov 2015 New trial record